Endocrinology, Vol 137, 2308-2314, Copyright © 1996 by Endocrine Society

ARTICLES

11 beta-Hydroxysteroid dehydrogenase type 2 complementary deoxyribonucleic acid stably transfected into Chinese hamster ovary cells: specific inhibition by 11 alpha-hydroxyprogesterone

H Morita, M Zhou, MF Foecking, EP Gomez-Sanchez, EN Cozza and CE Gomez-Sanchez
Department of Internal Medicine, University of Missouri, Columbia 65212, USA.

The 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta HSD-2) enzyme is thought to confer aldosterone specificity upon mineralocorticoid target tissues by protecting the mineralocorticoid receptor from binding by the more abundant glucocorticoids, corticosterone and cortisol. We have developed a Chinese hamster ovary cell line stably transfected with a plasmid containing the rat 11 beta HSD-2 complementary DNA. This cell line has expressed the enzyme consistently for many generations. The 11 beta HSD-2 was located primarily in the microsomes, but significant amounts also existed in the nuclei and mitochondria. The enzymatic reaction was unidirectional, oxidative, and inhibited by the product, 11-dehydrocorticosterone, with an IC50 of approximately 200 nM. The K(m) for corticosterone was 9.6 +/- 3.1 nM, and that for NAD+ was approximately 8 microM. The enzyme did not convert dexamethasone to 11-dehydrodexamethasone. Tunicamycin, an N- glycosylation inhibitor, had no effect on enzyme activity. 11 alpha- Hydroxyprogesterone (11 alpha OH-P) was an order of magnitude more potent a competitive inhibitor of the 11 beta HSD-2 than was glycyrrhetinic acid (GA) (approximate IC50 = 0.9 vs. 15 nM). 11 beta OH- P, progesterone, and GA were almost equipotent (IC50 = 10 and 6 nM, respectively), and 5 alpha-pregnandione and 5 beta-pregnandione were less potent (IC50 = 100 and 500 nM, respectively) inhibitors of the enzyme. When the inhibitory activities were examined with intact transfected cells, 11 alpha OH-P was more potent than GA (IC50 = 5 and 150 nM, respectively). 11 alpha OH-P was not metabolized by 11 beta HSD- 2. We were unable to demonstrate the presence of 11 alpha OH-P in human urine. In conclusion, a cell line stably transfected with the rat 11 beta HSD-2 was created, and the enzyme kinetics, including inhibition, were characterized. 11 alpha OH-P was found to be a potent relatively specific inhibitor of the 11 beta HSD-2 enzyme. Its potential importance is that it is the most specific inhibitor of the 11 beta HSD- 2 so far encountered and would aid in the study of the physiological importance of the isoenzyme.

This article has been cited by other articles:

				E. P. Gomez-Sanchez, D. G. Romero, A. F. de Rodriguez, M. P. Warden, Z. Krozowski, and C. E. Gomez-Sanchez Hexose-6-Phosphate Dehydrogenase and 11{beta}-Hydroxysteroid Dehydrogenase-1 Tissue Distribution in the Rat Endocrinology, February 1, 2008; 149(2): 525 - 533. [Abstract] [Full Text] [PDF]

				V. Sharp, L. M Thurston, R. C Fowkes, and A. E Michael 11{beta}-Hydroxysteroid dehydrogenase enzymes in the testis and male reproductive tract of the boar (Sus scrofa domestica) indicate local roles for glucocorticoids in male reproductive physiology Reproduction, September 1, 2007; 134(3): 473 - 482. [Abstract] [Full Text] [PDF]

				J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart 11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response Endocr. Rev., October 1, 2004; 25(5): 831 - 866. [Abstract] [Full Text] [PDF]

				E. P. Gomez-Sanchez, V. Ganjam, Y. J. Chen, Y. Liu, M. Y. Zhou, C. Toroslu, D. G. Romero, M. D. Hughson, A. de Rodriguez, and C. E. Gomez-Sanchez Regulation of 11{beta}-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E272 - E279. [Abstract] [Full Text] [PDF]

				N. Alfaidy, S. Gupta, C. DeMarco, I. Caniggia, and J. R. G. Challis Oxygen Regulation of Placental 11{beta}-Hydroxysteroid Dehydrogenase 2: Physiological and Pathological Implications J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4797 - 4805. [Abstract] [Full Text] [PDF]

				P. Heilmann, E. Buchheim, J. Wacker, and R. Ziegler Alteration of the Activity of the 11{beta}-Hydroxysteroid Dehydrogenase in Pregnancy: Relevance for the Development of Pregnancy-Induced Hypertension? J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5222 - 5226. [Abstract] [Full Text] [PDF]

				N. Alfaidy, Z. G. Xiong, L. Myatt, Stephen. J. Lye, J. F. MacDonald, and J. R. G. Challis Prostaglandin F2{alpha} Potentiates Cortisol Production by Stimulating 11{beta}-Hydroxysteroid Dehydrogenase 1: A Novel Feedback Loop That May Contribute to Human Labor J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5585 - 5592. [Abstract] [Full Text] [PDF]

				A. Odermatt, P. Arnold, A. Stauffer, B. M. Frey, and F. J. Frey The N-terminal Anchor Sequences of 11beta -Hydroxysteroid Dehydrogenases Determine Their Orientation in the Endoplasmic Reticulum Membrane J. Biol. Chem., October 1, 1999; 274(40): 28762 - 28770. [Abstract] [Full Text] [PDF]

				E. P. Gomez-Sanchez and C. E. Gomez-Sanchez Maternal Hypertension and Progeny Blood Pressure : Role of Aldosterone and 11ß-HSD Hypertension, June 1, 1999; 33(6): 1369 - 1373. [Abstract] [Full Text] [PDF]

				J. Tremblay, D.B. Hardy, L.E. Pereira, and K. Yang Retinoic Acid Stimulates the Expression of 11ß-Hydroxysteroid Dehydrogenase Type 2 in Human Choriocarcinoma JEG-3 Cells Biol Reprod, March 1, 1999; 60(3): 541 - 545. [Abstract] [Full Text]

				K. E. Sheppard, K. Khoo, Z. S. Krozowski, and K. X. Z. Li Steroid specificity of the putative DHB receptor: evidence that the receptor is not 11beta HSD Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E124 - E131. [Abstract] [Full Text] [PDF]